We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Set of External Quality Assessment Programs Launched

By LabMedica International staff writers
Posted on 20 Dec 2015
Print article
A set of eight new RIQAS external quality assessment (EQA; also referred to as proficiency testing (PT)) programs have been launched to provide clinical laboratories with the ability to review calibration issues and systematic errors and to monitor accuracy and bias. They also enable laboratories to assess analytical performance in comparison with other laboratories that employ the same instrument or methods. 

Developed by Randox Quality Control of Randox (Crumlin, United Kingdom), the eight new RIQAS (Randox International Quality Assessment Scheme) EQA programs are: CSF, Sweat Testing, Immunosuppressants, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor, and Cyfra 21-1. Cycles are scheduled to begin in March 2016.

The programs are available in liquid and lyophilized formats, covering the full clinical decision range, reassuring clinicians and patients that the laboratory is releasing accurate, reliable results. Monthly reporting supports rapid identification of errors and implementation of necessary corrective actions, thereby saving on expenses, resources, and valuable time by eliminating the need for patient sample retests. Randox QC’s rapid report turnaround will ensure that results are received within 24–72 hours. If required, corrective actions can then be implemented before the next cycle, providing more peace of mind.

RIQAS is the largest international EQA scheme, used by more than 32,000 laboratory participants in 123 countries. Such a large set of international peer groups provides increased confidence of the statistical validity of the extensive database of instrument and method results. 

Related Links:

Randox
Randox Quality Control
RIQAS 
 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.